Lactate inhibits T-cell activation in sepsis through CD40LG downregulation and SOCS3-mediated JAK1/STAT3 pathway

Hui Zhang1, Fanbing Meng1, Jinxuan Tang1

  • 1Department of Anesthesiology and Perioperative Medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai 200434, China.

Abstract

Insights

Elevated lactate levels in sepsis suppress T cell activation by downregulating CD40LG and SOCS3, impacting kinase activity and immune cell function. This study identifies key genes involved in lactate-induced immunosuppression.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Lactate, a marker of sepsis severity, influences kinase activity and immune suppression.
  • Understanding lactate's impact on immune cells and kinases is crucial for sepsis management.

Purpose of the Study:

  • To investigate the effects of lactate on kinase activity and immune cells in sepsis.
  • To identify key genes regulating the interactions between lactate, kinases, and immune cells.

Main Methods:

  • Differential gene expression analysis (limma) to identify sepsis-related genes.
  • Correlation analysis between lactate-related DEGs (lrDEGs) and kinase-related DEGs (krDEGs).
  • Hub gene identification (CytoHubba, WGCNA) and immune cell profiling (xCell).

Main Results:

  • A significant correlation between lrDEGs and krDEGs was observed in sepsis patients.
  • Eight hub genes were identified, with strong associations between lrDEGs/krDEGs and T lymphoid cell scores.
  • CD40LG and SOCS3 were identified as critical regulators of T cell function, linked to lrDEGs.

Conclusions:

  • Lactate inhibits T lymphocyte activation in sepsis via altered kinase-related gene expression.
  • Elevated lactate downregulates CD40LG and SOCS3, suppressing T cells by inhibiting the JAK-STAT pathway.